Adalat Overdose

If you believe you may have overdosed on Adalat CC, seek immediate medical attention. Some symptoms of an Adalat CC overdose include dizziness, fainting, and difficulty breathing. Treating a recent overdose may involve pumping the stomach or administering certain medications. Treatment may also involve supportive care, which consists of treating the symptoms that occur as a result of the overdose.

Adalat Overdose: An Overview

Adalat CC® (nifedipine) is a prescription medication known as a calcium channel blocker. It is used to treat high blood pressure (hypertension). The effects of an Adalat CC overdose will vary depending on a number of factors, including how much Adalat CC was taken and whether it was taken with any other medicines, alcohol, and/or street drugs.
 
If you happen to overdose on Adalat CC, seek immediate medical attention.
 

Symptoms of an Adalat Overdose

Adalat CC overdose symptoms may include:
 
  • Low blood pressure (hypotension)
  • Loss of consciousness
  • An irregular heart rhythm (arrhythmia)
  • Fluid in the lungs.
     
This may cause signs or symptoms that include:
 
  • Lightheadedness
  • Dizziness
  • Fainting
  • Difficulty breathing.
     

Treatment for an Adalat Overdose

The treatment for an Adalat CC overdose will vary.
 If the overdose was recent, a healthcare provider may use certain medicines or place a tube into the stomach to "pump the stomach." Treatment may also involve supportive care. This type of care consists of treating the symptoms that occur as a result of the overdose. For example, supportive treatment options may include:
 
  • Fluids through an intravenous line (IV)
  • Medications to increase blood pressure or correct an arrhythmia
  • Other treatments based on the complications that occur
  • Close monitoring of the heart and lungs.
     
It is important that you seek medical attention immediately if you believe that you may have overdosed on Adalat CC.
Written by/reviewed by: Kristi Monson, PharmD; Arthur Schoenstadt, MD
Last reviewed by: Kristi Monson, PharmD
Other Articles in This eMedTV Presentation